Michelle Rosenzwajg (M Rosenzwajg)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

Annals of the rheumatic diseases

RMD open

Molecular psychiatry

Journal of neurology

UPMC Faculte de Medecine Site Pitie-Salpetriere

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UPMC Faculte de Medecine Site Pitie-Salpetriere Sep 01 1999

France

MCU-PH :: I3

Publications

François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsenne Mekinian
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD open 10 (2) (2024)
François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsenne Mekinian
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD open 10 (2) (2024)
François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsenne Mekinian
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD open 10 (2) (2024)
François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsenne Mekinian
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD open 10 (2) (2024)
François Barde, Roberta Lorenzon, Eric Vicaut, Sébastien Rivière, Patrice Cacoub, Carlotta Cacciatore, Michelle Rosenzwajg, Anne Daguenel-Nguyen, Olivier Fain, David Klatzmann, Arsenne Mekinian
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study. RMD open 10 (2) (2024)
Nicolas Tchitchek, Marie Binvignat, Alexandra Roux, Fabien Pitoiset, Johanna Dubois, Gwendolyn Marguerit, David Saadoun, Patrice Cacoub, Jérémie Sellam, Francis Berenbaum, Agnès Hartemann, Chloé Amouyal, Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Michelle Rosenzwajg, David Klatzmann
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Annals of the rheumatic diseases 83 (5) (2024)
Nicolas Tchitchek, Marie Binvignat, Alexandra Roux, Fabien Pitoiset, Johanna Dubois, Gwendolyn Marguerit, David Saadoun, Patrice Cacoub, Jérémie Sellam, Francis Berenbaum, Agnès Hartemann, Chloé Amouyal, Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Michelle Rosenzwajg, David Klatzmann
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Annals of the rheumatic diseases 83 (5) (2024)
Nicolas Tchitchek, Marie Binvignat, Alexandra Roux, Fabien Pitoiset, Johanna Dubois, Gwendolyn Marguerit, David Saadoun, Patrice Cacoub, Jérémie Sellam, Francis Berenbaum, Agnès Hartemann, Chloé Amouyal, Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Michelle Rosenzwajg, David Klatzmann
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Annals of the rheumatic diseases 83 (5) (2024)
Anne Molitor, Alexandre Lederle, Mirjana Radosavljevic, Vinay Sapuru, Megan E Zavorka Thomas, Jianying Yang, Mahsa Shirin, Virginie Collin-Bund, Katerina Jerabkova-Roda, Zhichiao Miao, Alice Bernard, Véronique Rolli, Pierre Grenot, Carla Noemi Castro, Michelle Rosenzwajg, Elyssa G Lewis, Richard Person, Uxía-Saraiva Esperón-Moldes, Milja Kaare, Pekka T Nokelainen, Nurit Assia Batzir, Gal Zaks Hoffer, Nicodème Paul, Tristan Stemmelen, Lydie Naegely, Antoine Hanauer, Sabrina Bibi-Triki, Sarah Grün, Sophie Jung, Ignacio Busnelli, Kornelia Tripolszki, Ruslan Al-Ali, Natalia Ordonez, Peter Bauer, Eunkyung Song, Kristin N Zajo, Santiago Partida-Sanchez, Frank H Robledo-Avila, Attila Kumánovics, Yoram Louzoun, Aurélie Hirschler, Angélique Pichot, Ori Toker, Cesar Andrés Muñoz Mejía, Nima Parvaneh, Esther Knapp, Joseph H Hersh, Heather Kenney, Ottavia Maria Delmonte, Luigi Daniele Notarangelo, Jacky G Goetz, Samir B Kahwash, Christine Carapito, Rajinder P S Bajwa, Caroline Thomas, Stephan Ehl, Bertrand Isidor, Raphaël Carapito, Roshini S Abraham, Richard K Hite, Nufar Marcus, Aida Bertoli-Avella, Seiamak Bahram
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease. Science advances 10 (37) (2024)
Nicolas Tchitchek, Marie Binvignat, Alexandra Roux, Fabien Pitoiset, Johanna Dubois, Gwendolyn Marguerit, David Saadoun, Patrice Cacoub, Jérémie Sellam, Francis Berenbaum, Agnès Hartemann, Chloé Amouyal, Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Michelle Rosenzwajg, David Klatzmann
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Annals of the rheumatic diseases (2024)
Nicolas Tchitchek, Marie Binvignat, Alexandra Roux, Fabien Pitoiset, Johanna Dubois, Gwendolyn Marguerit, David Saadoun, Patrice Cacoub, Jérémie Sellam, Francis Berenbaum, Agnès Hartemann, Chloé Amouyal, Roberta Lorenzon, Encarnita Mariotti-Ferrandiz, Michelle Rosenzwajg, David Klatzmann
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Annals of the rheumatic diseases 83 (5) (2024)
Pierre Ellul, Isabelle Melki, Stephanie Antoun, Laura Lavialle, Eric Acquaviva, Florence A Aeschlimann, Brigitte Bader-Meunier, Alexandre Belot, Glory Dingulu, Cecile Dumaine, Albert Faye, Marie-Louise Frémond, Ulrich Meinzer, Hugo Peyre, Pierre Quartier, Michelle Rosenzwajg, Isabelle Savioz, Caroline Vinit, Nicolas Tchitchek, David Klatzmann, Richard Delorme
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysis. Molecular psychiatry (2023)
Céline Louapre, Michelle Rosenzwajg, M Golse, A Roux, F Pitoiset, L Adda, N Tchitchek, C Papeix, E Maillart, A Ungureanu, F Charbonnier-Beaupel, D Galanaud, J C Corvol, E Vicaut, C Lubetzki, David Klatzmann
A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis. Journal of neurology (2023)
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stephane R Ederhy, Alban Redhueil, Samia Boussouar, Lee S Nguyen, Adrien Procureur, Frederic Stein, Charlotte Fenioux, Perrine Devos, Paul Gougis, Martin Dres, Alexandre Demoule, Dimitri Psimaras, Timothee Lenglet, Thierry Maisonobe, Marc Pineton de Chambrun, Guillaume Hékimian, Christian Straus, Jésus Gonzalez-Bermejo, David Klatzmann, Aude Rigolet, Perrine Guillaume-Jugnot, Nicolas Champtiaux, Olivier Benveniste, Nicolas Weiss, Samir Saheb, Philippe Rouvier, Isabelle Plu, Estelle Gandjbakhch, Mathieu Kerneis, Nadjib Hammoudi, Noel Zahr, Claudia Llontop, Capucine Morélot-Panzini, Lorenz H Lehmann, Juan Qin, Javid J Moslehi, Michelle Rosenzwajg, Caroline Sévoz-Couche, Yves Allenbach
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer discovery (2023)
Paul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, Guillaume Darrasse-Jèze, Charles Dolladille, Wouter C Meijers, Lisa Bastarache, Pierre Fouret, Patrick Bruneval, Floriane Arbaretaz, Célia Sayetta, Ana Márquez, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub, Javid J Moslehi, Joe-Elie Salem, David Saadoun
CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis. Circulation research (2023)
Pierre Ellul, Isabelle Melki, Stephanie Antoun, Laura Lavialle, Eric Acquaviva, Florence A Aeschlimann, Brigitte Bader-Meunier, Alexandre Belot, Glory Dingulu, Cecile Dumaine, Albert Faye, Marie-Louise Frémond, Ulrich Meinzer, Hugo Peyre, Pierre Quartier, Michelle Rosenzwajg, Isabelle Savioz, Caroline Vinit, Nicolas Tchitchek, David Klatzmann, Richard Delorme
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysis. Molecular psychiatry (2023)
Jens Y Humrich, Patrice Cacoub, Michelle Rosenzwajg, Fabien Pitoiset, Hang Phuong Pham, Joel Guidoux, David Leroux, Thomas Vazquez, Gabriela Riemekasten, Josef S Smolen, George C Tsokos, David Klatzmann
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial. Annals of the rheumatic diseases 81 (12) (2022)
Pierre Ellul, Eric Acquaviva, Hugo Peyre, Michelle Rosenzwajg, Pierre Gressens, David Klatzmann, Richard Delorme
Parental autoimmune and autoinflammatory disorders as multiple risk factors for common neurodevelopmental disorders in offspring: a systematic review and meta-analysis. Translational psychiatry 12 (1) (2022)
Michelle Rosenzwajg, Roberta Lorenzon, David Klatzmann
Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer et al. Annals of the rheumatic diseases 80 (12) (2020)
Paul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, Anne Claire Desbois, Cloé Comarmond, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub, David Saadoun
Targeting JAK/STAT pathway in Takayasu's arteritis. Annals of the rheumatic diseases 79 (7) (2020)
Michelle Rosenzwajg, Randa Salet, Roberta Lorenzon, Nicolas Tchitchek, Alexandra Roux, Claude Bernard, Jean-Claude Carel, Caroline Storey, Michel Polak, Jacques Beltrand, Chloé Amouyal, Agnès Hartemann, Pierre Corbeau, Eric Vicaut, Cecile Bibal, Pierre Bougnères, Tu-Anh Tran, David Klatzmann
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study. Diabetologia 63 (9) (2020)
Fabien Pitoiset, Michèle Barbié, Guillaume Monneret, Cécile Braudeau, Pierre Pochard, Isabelle Pellegrin, Jacques Trauet, Myriam Labalette, David Klatzmann, Michelle Rosenzwajg
A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials. Cytometry. Part B, Clinical cytometry 94 (5) (2018)
Michelle Rosenzwajg, Roberta Lorenzon, Patrice Cacoub, Hang Phuong Pham, Fabien Pitoiset, Karim El Soufi, Claire RIbet, Claude Bernard, Selim Aractingi, Beatrice Banneville, Laurent Beaugerie, Francis Berenbaum, Julien Champey, Olivier Chazouilleres, Christophe Corpechot, Bruno Fautrel, Arsenne Mekinian, Elodie Regnier, David Saadoun, Joe-Elie Salem, Jérémie Sellam, Philippe Seksik, Anne Daguenel-Nguyen, Valérie Doppler, Jéremie Mariau, Eric Vicaut, David Klatzmann
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Annals of the rheumatic diseases 78 (2) (2018)

Michelle Rosenzwajg.css-eqlu8i{font-size:small;padding-left:4px;} (M Rosenzwajg)

Publication Activity (10 Years)

Top Topics

Top Venues

Michelle Rosenzwajg (M Rosenzwajg)